Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cancer Research Group - Collaborative Group (CRG-CG) is an independent clinical research organization founded in 2003 and based in Beirut, Lebanon. The group specializes in the design, coordination, and sponsorship of multicenter oncology clinical trials, serving as a vital research hub for the Middle East and North Africa (MENA) region. Led by President Dr. Fadi Farhat, CRG-CG collaborates with leading academic medical centers and university hospitals to advance cancer treatment standards. Their research portfolio primarily focuses on solid tumors, with significant contributions to the study of breast cancer therapies, including maintenance chemotherapy and novel drug combinations. The organization is also a key member of the Africa Middle East Cancer Intergroup (AMCI), fostering international research collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cancer Research Group - Collaborative Group.